Serum levels of the soluble IL-1 receptor family member ST2 and right ventricular dysfunction

Biomarkers in Medicine

Volumn 8, Issue 1, 2014, Pages 95-106

  Agoston Coldea, Lucia ^a   Lupu, Silvia ^b   Hicea, Sergiu ^a   Paradis, Armony ^a   Mocan, Teodora ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

NT proBNP; pulmonary hypertension; right ventricular dysfunction; soluble interleukin receptor family member

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; SOLUBLE INTERLEUKIN 1 RECEPTOR; SOLUBLE INTERLEUKIN 2 RECEPTOR; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AREA UNDER THE CURVE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PULMONARY HYPERTENSION; RECEIVER OPERATING CHARACTERISTIC; SYSTOLIC BLOOD PRESSURE;

AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LINEAR MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, CELL SURFACE; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84890606781     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.13.116     Document Type: Article

References (31)

1. Bogaard HJ, Abe K, Noordegraaf AV, Voelkel NF. The right ventricle under pressure. Cellular and molecular mechanisms of right heart failure in pulmonary hypertension. Chest 135(3), 794-804 (2009
2. Pokreisz P, Marsboom G, Janssens S. Pressure overload-induced right ventricular dysfunction and remodelling in experimental pulmonary hypertension: The right heart revisited. Eur. Heart J. Suppl. 9(Suppl. H), S75-S84 (2007
3. Innelli P, Esposito R, Olibet M, Nistri S, Galderisi M. The impact of ageing on right ventricular longitudinal function in healthy subjects: A pulsed tissue Doppler study. Eur. J. Echocardiogr. 10(4), 491-498 (2009
4. Lopez-Candales A, Rajagopalan N, Saxena N, Gulyasy B, Edelman K, Bazaz R. Right ventricular systolic function is not the sole determinant of tricuspid annular motion. Am. J. Cardiol. 98(7), 973-977 (2006
5. Badano LP, Ginghina C, Easaw J et al. Right ventricle in pulmonary arterial hypertension: Hameodynamics, structural changes, imaging, and proposal of a study protocol aimed to assess remodelling and treatment effects. Eur. J. Echocardiogr. 11(1), 27-37 (2010
6. Weir RA, Miller AM, Murphy GE et al. Serum soluble ST2: A potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction. J. Am. Coll. Cardiol. 55(3), 243-250 (2010
7. Mueller T, Dieplinger B, Gegenhuber A, Poelz W, Pacher R, Haltmayer M. Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure. Clin. Chem. 54(4), 752-756 (2008
8. Manzano-Fernández S, Mueller T, Pascual-Figal D, Truong QA, Januzzi JL. Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction. Am. J. Cardiol. 107(2), 259-267 (2011
9. Chi SY, Kim EY, Ban HJ et al. Plasma N-Terminal pro-brain natriuretic peptide: A prognostic marker in patients with chronic obstructive pulmonary disease. Lung 190(3), 271-276 (2012
10. Hoiseth AD, Omland T, Hagve TA, Brekke PH, Sayseth V. NT-proBNP independently predicts long term mortality after acute exacerbation of COPD-A prospective cohort study. Respir. Res. 13(1), 97 (2012
11. Miller AM. Role of IL-33 in inflammation and disease. J. Inflamm. 8(1), 22 (2011
12. Shah KB, Kop WJ, Christenson RH et al. Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction. Clin. Chem. 57(6), 874-882 (2011
13. Dieplinger B, Gegenhuber A, Kaar G, Poelz W, Haltmayer M, Mueller T. Prognostic value of established and novel biomarkers in patients with shortness of breath attending an emergency department. Clin. Biochem. 43(9), 714-719 (2010
14. Weinberg EO, Shimpo M, De Keulenaer GW et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 106(23), 2961-2966 (2002
15. Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J. Clin. Invest. 117(6), 1538-1549 (2007
16. Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin; ADHERE scientific advisory committee and investigators. Admission B-Type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J. Am. Coll. Cardiol. 49(19), 1943-1950 (2007
17. Januzzi J, Peacock W, Maisel A et al. Measurement of the interleukin family member ST2 in patients with acute dyspnea: Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. J. Am. Coll. Cardiol. 50(7), 607-613 (2007
18. Shimpo M, Morrow DA, Weinberg EO et al. Serum levels of the interleukin-1 receptor family member ST2 predicts mortality and clinical outcome in acute myocardial infarction. Circulation 109(18), 2186-2190 (2004
19. Sabatine MS, Morrow DA, Higgins LJ et al. Complementary roles for biomarkers of biomechanical strain ST2 and N-Terminal prohormone B-Type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation 117(15), 1936-1944 (2008
20. Weimberg EO, Shimpo M, Hurwitz S, Tominaga S, Rouleau JL, Lee RT. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 107(5), 721-726 (2003
21. Pascual-Figal DA, Ordoñez-Llanos J, Tornel PL et al. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction. J. Am. Coll. Cardiol. 54(23), 2174-2179 (2009
22. Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RJ, Januzzi JL. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-Term mortality in patients with acute dyspnea. Circ. Heart Fail. 2(4), 311-319 (2009
23. Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 176(6), 532-555 (2007
24. Lang RM, Bierig M, Devereux RB et al. Recommendations for chamber quantification: A report from the American society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology. J. Am. Soc. Echocardiogr. 18(12), 1440-1463 (2005
25. Rudski LG, Lai WW, Ålalo J et al. Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr. 23(7), 685-713 (2010
26. Ky B, French B, McCloskey K et al. Highsensitivity ST2 for prediction of adverse outcomes in chronic heart failure. Circ. Heart Fail. 4(2), 180-187 (2011
27. Pascual-Figal DA, Manzano-Fernandez S, Boronat M et al. Soluble ST2, high-sensitivity troponin T-And N-Terminal pro-B-Type natriuretic peptide: Complementary role for risk stratification in acutely decompensated heart failure. Eur. J. Heart Fail. 13(7), 718-725 (2011
28. Westermann D, Lindner D, Kasner M et al. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ. Heart Fail. 4(1), 44-51 (2011
29. McMurray JJ, Adamopoulos S, Anker SD et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur. J. Heart Fail. 14(8), 803-869 (2012
30. Miller AM, Asquith DL, Hueber AJ et al. Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ. Res. 107(5), 650-658 (2010
31. Fousteris E, Melidonis A, Panoutsopoulos G et al. Toll/interleukin-1 receptor member ST2 exhibits higher soluble levels in Type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction. Cardiovasc. Diabetol. 10, 101 (2011